The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its assessment of FDA's premarket clearance process for medical devices, the IOM held a workshop June 14-15 to discuss how to best balance patient safety and technological innovation. This document summarizes the workshop.
Table of Contents
|2 Legislative History of the Medical Device Amendments of 1976||3-6|
|3 Premarket Notification||7-16|
|4 The Medical Device Industry Innovation Ecosystem||17-34|
|5 The Global Framework for Regulation of Medical Devices||35-52|
|6 Public Comments||53-62|
|Appendix A: Workshop Agenda||63-66|
|Appendix B: Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned Papers||67-74|
|Appendix C: Premarket Notification: A Key Element of US Medical Device Regulation--Larry Kessler and Philip J. Phillips||75-112|
|Appendix D: Impact of the Regulatory Framework on Medical Device Development and Innovation--David W. Feigal, Jr.||113-128|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report...